Arthneeti
PC

Prasol Chemicals Ltd

Q1 FY27Chemicals & Petrochemicals

Prasol Chemicals Q1 FY27: Revenue ₹433.6 Cr, PAT ₹61.0 Cr

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹764
Market cap₹4.5K Cr
P/E53.3
Updated28 Sept 2026
Read4 min read

Based on Prasol Chemicals Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q1 FY27 Revenue from Operations: ₹433.6 crores - Q1 FY26 Revenue from Operations: ₹319.6 crores - Year-on-year revenue growth: +35.5% (Page 10) / +36% (Page 8) - Growth drivers: steady volume gr Q1 FY27 EBITDA: ₹90.3 crores, up 122.4% YoY from ₹40.6 crores in Q1 FY26 - Q1 FY27 EBITDA Margin: 20.8%, vs 12.7% in Q1 FY26 - Q1 FY27 Profit After Tax (PAT): ₹61.0 crores, up 150.7% YoY from ₹24.

From Prasol Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 28 Sept 2026.

Revenue & Sales Performance

  • Q1 FY27 Revenue from Operations: ₹433.6 crores
  • Q1 FY26 Revenue from Operations: ₹319.6 crores
  • Year-on-year revenue growth: +35.5% (Page 10) / +36% (Page 8)
  • Growth drivers: steady volume growth, better product mix, higher realizations (Page 7)
  • Domestic sales: strong growth in value and volume (Page 7)
  • Exports: year-on-year growth; geopolitical tensions impacted shipments (Page 7)
  • Outlook: FY27 revenue expected at ₹1,550–1,650 crores (Page 6)

2 more points management made on revenue & sales performance

Profitability & Margins

See what Prasol Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capacity Expansion in Two Phases (FY26-FY30):
  • Phase I: Expansion of existing products capacity from 98,844 to 158,844 MTPA (+61%)
  • Capex: Rs. 250-300 crores
  • Includes debottlenecking and process augmentation at Khopoli & Mahad units + Rs. 50-60 crores for land & infrastructure
  • Multiple sub-phases over next 2 years; expected revenue at peak utilization Rs. 500-550 crores
  • Utilization as of FY26: 70-72%
  • Phase II: New R&D products capacity
  • Capex: Rs. 250-300 crores
  • Investment of Rs. 50-60 crores for infrastructure development
  • Products identified; site prep and regulatory approvals in progress
  • Capex spend to begin H2FY28
  • General Capex Funding: Funded through internal accruals and debt

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Prasol Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any figures or details regarding order book, order inflow, or pending orders. Specifically: - No mention of order book size or value. - No data on the inflow of new orders. - No information on pending or backlog orders. The presentation focuses mainly on financial performance, capacity expansion plans, operational efficiencies, product developments, and market presence but does not provide explicit data on orders or order pipeline.

Continue your research

Others in Chemicals & Petrochemicals this season

  • Vipul Organics Ltd (Q1 FY27)

    Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…

  • Fine Organic Industries Ltd (Q1 FY27)

    Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

  • Chemfab Alkalis Ltd (Q1 FY27)

    Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…

  • Gujarat Alkalies & Chemicals Ltd (Q1 FY27)

    Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q1 FY27 earnings call — and…

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Prasol Chemicals Ltd Q1 FY27 results?

Q1 FY27 Revenue from Operations: ₹433.6 crores - Q1 FY26 Revenue from Operations: ₹319.6 crores - Year-on-year revenue growth: +35.5% (Page 10) / +36% (Page 8) - Growth drivers: steady volume gr Q1 FY27 EBITDA: ₹90.3 crores, up 122.4% YoY from ₹40.6 crores in Q1 FY26 - Q1 FY27 EBITDA Margin: 20.8%, vs 12.7% in Q1 FY26 - Q1 FY27 Profit After Tax (PAT): ₹61.0 crores, up 150.7% YoY from ₹24.

What is Prasol Chemicals Ltd share price analysis?

Prasol Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 53.3 with a market cap of ₹4,474 Cr. Investors should review the full earnings analysis for detailed insights.

Is Prasol Chemicals Ltd planning capital expenditure?

Capacity Expansion in Two Phases (FY26-FY30): - Phase I: Expansion of existing products capacity from 98,844 to 158,844 MTPA (+61%) - Capex: Rs.

Keep Prasol Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.